Tiny drug-laden ‘popping bubbles’ lead triple attack treatment for liver cancer
In an interdisciplinary collaboration between prominent academic and industry investigators, researchers have discovered a novel method for repositioning an FDA-approved anti-cancer compound so it can specifically target liver cancer tumours. A
